Hypoglycaemic and hypolipidemic activity of methanolic root extract of Caesalpinia digyna (Rottler) in streptozotocin-induced diabetic rats

Pharmacologyonline

Volumn 2, Issue , 2008, Pages 781-789

  Sarath Chandiran, I ^a   Vrushabendra Swamy, B M ^b   Pavan Kumar, B ^a   Narayanan, V ^a   Vinoth Kumar, S ^a   Muralidharan, P ^c   Karimulla, S K ^c  

^a Gokula Krishna College of Pharmacy   (India)

^b Srinivasa Institute of Pharmaceutical Sciences   (India)

^c C L BAID METHA COLLEGE OF PHARMACY   (India)

Author keywords

Caesalpinia digyna root; Hypoglycaemic activity; Hypolipidemic activity; Lipid profile; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CAESALPINIA DIGYNA EXTRACT; CHOLESTEROL; CREATINE; GLIBENCLAMIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; METHANOL; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; LOW DRUG DOSE; MALE; NONHUMAN; PLANT ROOT; PROTEIN BLOOD LEVEL; RAT; SOLVENT EXTRACTION; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE;

EID: 53249103334     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Anon. The wealth of India. Vol.3. CSIR, New Delhi: India 1992:12-13.
2. Srinivasan R, Chandrasekar MJN, Nanjan MJ, Suresh B, Antioxidant activity of Caesalpinia digyna root. J Ethnopharmacol 2007;113(2):284-291.
3. Kritikar KR.,Basu BD.Indian Medicinal Plants,vol.2.International Booksellers and Publishers: Dehradun: India, 1999:851.
4. Rahul Somani, Sanjay Kasture, Abhay Kumar Singhai..Antidiabetic potential of butea monosperma in rats. Fitoterapia 2006; 77:80-90.
5. Shirwaikar A, Rajendran K, Rakesh,Barik. Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozocin - nicotinamide induced type-II diabetic mellitus. J Ethanopharmacol 2006; 107:285-290.
6. Muruganandam S, Srinivasan K, Gupta S, Gupta PK. Effect of Magniferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethanopharmacol 2005; 97:497-501.
7. Singhavi AK, Aherwar B. Effect of terminalia chebula fruits on Lipid profile of rats. J Nat Rem 2003; 3:31-35.
8. Swanston-Flat SK, DayC, Bailey CJ, Flatt PR. Traditional plant treatment for diabetes: studies in normal and streptozotocin diabetic mice. Diabetologia 1990; 33:462-464.
9. Chattejea MN, Shinde R. Text Book of Medical biochemistry. Jaypee Brothers Medical Publishers, New Delhi, 2002:317.
10. Apparao C, Kameswararao B, Kesavulu MM. Evaluation of Antidiabetic effect of Momordica cymbalaria fruit in alloxan-diabetic rats. Fitoterapia 2003; 74:7-13.
11. Ronald Khan.,George EK, Allanc Moses. JOSLIN's DIABETES MELLITUS. Elesiver Publication, 1995; 14:12.
12. Latner A, Carbohydrate metabolism.Abnormalities of post absorptive blood sugar level. Clinical Biochemistry.2nd ed.Philadelphia,PA:WB Saunders; 1958.p,48.
13. Vinal Kumar, Abul K, Nelson Fuasto, Richard N.Mitchell.Robbins Basic Pathology,Elsevier Publication ,8th Edition, 2007, p:781
14. Riyad A, Abdul-Ghani Abul-Salam S, Suleiman SM. Plant Med 1988; 54:286.
15. Tarfa SP, Joseph PK, Augusti KT..Curr Sci 1988; 57:32.
16. Sharma SR, Dwivewdi SK, Swarup D. Indian J Exp Biol 1996; 34:372.
17. Gupta S, Kataria M, Gupta PK, Murganandan S, Yashroy RC. Protective role of extracts of neem seeds in diabetes caused by streptozotocin in rats. J Ethanopharmacol 2004; 90:185-189.